22.86

2.10% 0.49

Phibro Animal Health Corp (PAHC)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Phibro Animal Health Corp stock is traded at $22.86, with a volume of 72,425. It is up +2.10% in the last 24 hours and up +7.18% over the past month. Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Previous Close:

$22.37

Open:

$22.23

24h Volume:

72,425

Relative Volume:

0.41

Market Cap:

$906.07M

Revenue:

$982.01M

Net Income/Loss:

$14.80M

P/E Ratio:

27.88

EPS:

0.82

Net Cash Flow:

$37.02M

1W Performance:

-2.81%

1M Performance:

+7.18%

6M Performance:

+33.80%

1Y Performance:

+85.09%

1-Day Range:

$22.16

$22.92

1-Week Range:

$22.16

$23.94

52-Week Range:

$9.40

$25.11

Phibro Animal Health Corp Stock (PAHC) Company Profile

Name

Phibro Animal Health Corp

Sector

Healthcare (1181)

Industry

Drug Manufacturers - Specialty & Generic (88)

Phone

201-329-7300

Address

GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ

Employee

1,940

Twitter

@phibroeurope

Next Earnings Date

2024-11-06

Latest SEC Filings

PAHC's Discussions on Twitter

Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-21-22	Initiated	ROTH Capital	Buy
Jul-25-22	Downgrade	Barclays	Equal Weight → Underweight
Jan-10-22	Upgrade	Barclays	Underweight → Equal Weight
Nov-18-21	Initiated	Morgan Stanley	Equal-Weight
Aug-05-21	Resumed	Credit Suisse	Neutral
Jul-07-21	Downgrade	Barclays	Equal Weight → Underweight
Aug-06-20	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Feb-06-20	Downgrade	Gabelli & Co	Buy → Hold
Jan-28-20	Upgrade	Barclays	Underweight → Equal Weight
Sep-05-19	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Aug-29-19	Reiterated	BofA/Merrill	Underperform
Jun-11-19	Initiated	Barclays	Underweight
May-23-19	Initiated	Guggenheim	Neutral
May-09-19	Upgrade	Gabelli & Co	Hold → Buy
Aug-23-17	Resumed	BofA/Merrill	Underperform
Jun-02-17	Downgrade	Credit Suisse	Outperform → Neutral
Dec-15-16	Initiated	Piper Jaffray	Overweight
Nov-11-16	Downgrade	Macquarie	Neutral → Underperform
Nov-10-16	Downgrade	Gabelli & Co	Buy → Hold
Apr-11-16	Reiterated	Guggenheim	Buy
Feb-04-16	Initiated	Credit Suisse	Outperform
Jan-15-16	Downgrade	Barclays	Overweight → Underweight
Sep-30-15	Initiated	Gabelli & Co	Buy
Apr-24-15	Reiterated	Barclays	Overweight
Apr-21-15	Downgrade	Morgan Stanley	Equal-Weight → Underweight
May-06-14	Initiated	Barclays	Overweight

View All

Phibro Animal Health Corp Stock (PAHC) Latest News

08:01 AM